Baricitinib: Doctors Are Skeptical of This Covid-19 Drug From Eli Lilly
In mid-November, an arthritis drug with a tricky name hit a pandemic milestone — then slipped back into relative obscurity.The...
In mid-November, an arthritis drug with a tricky name hit a pandemic milestone — then slipped back into relative obscurity.The...
Over the past few weeks, a Harvard scientist has made headlines for a bold idea to curb the spread of...
Billions of dollars are being invested in the development of vaccines against the coronavirus. Until one arrives, many scientists have...